Federal Register of Legislation - Australian Government

Primary content

Declarations/Other as made
This Declaration specifies drugs and medicinal preparations that the delegate of the Minister has declared no longer to be pharmaceutical benefits under Part VII of the National Health Act 1953.
Administered by: Health
Registered 29 May 2007
Gazetted 23 Nov 1988
Date of repeal 24 Dec 2009
Repealed by Health and Ageing Revocation Instrument 2009 (No. 1)

COMMONWEALTH OF AUSTRALIA

NATIONAL HEALTH ACT 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUB-SECTION 85(2AA)

 

 


I, JOHN STEWART DEEBLE, Acting First Assistant Secretary, Health Benefits Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, pursuant to sub-section 85(2AA) of the National Health Act 1953, hereby make the following Declaration:

 

 

1.                              This Declaration shall come into operation on 1 December 1988.

 

2.                              The drugs and medicinal preparations contained in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

 

THE SCHEDULE

 

Atropine Methonitrate B.P.

Benzocaine B.P. with Adrenaline B.P.

Cholera Vaccine B.P.

Cloxacillin Sodium B.P. with Purified Water B.P.

Dapsone Tablets B.P.

Epicillin

Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.

Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and

Diphenhydramine Hydrochloride B.P.

Flucloxacillin Sodium B.P. with Purified Water B.P.

Natamycin

Norethisterone Acetate B.P. with Ethinyloestradiol B.P.

Ornidazole

Phenytoin Injection B.P.

Plague Vaccine B.P. 1973

Pyridostigmine Injection B.P.

Sodium Calciumedetate B.P.

Sodium Salicylate B.P.

Stilboestrol Tablets B.P.

Sulphamethizole B.P.

"Teric" N8 with Lauryldimethylbenzyl Ammonium Chloride

Trimetaphan Camsylate B.P. 1968

Typhoid Vaccine B.P.

Typhoid Vaccine, Oral

Typhus Vaccine B.P.

Anthrax Antiserum

Anthrax Vaccine

Antirabies Immunoglobulin Injection B.P.

Bacillus Calmette-Guerin Vaccine B.P.

Bacillus Calmette-Guerin Vaccine, Percutaneous B.P.

Black Snake Antivenom

Botulinum Antitoxin B.P.

Box Jellyfish Antivenom

Brown Snake Antivenom

Death Adder Antivenom

Formaldehyde Solution B.P.

Funnel-Web Spider Antivenom

Haemodialysis Solutions B.P.

Haemodialysis Solutions B.P.C. 1973

Haemodialysis Solutions, Concentrated B.P.

Haemodialysis Solutions, Concentrated B.P.C. 1973

Intraperitoneal Dialysis Solutions, Concentrated

Pituitary Gonadotrophin, Human

Pituitary Growth Hormone, Human

Rabies Vaccine B.P.

Snake Bite Antivenom, Polyvalent

Sodium Hypochlorite Solution, Strong B.P.

Sodium Hypochlorite Solution 52.5 mg per mL

Stone Fish Antivenom

Taipan Antivenom

Tiger Snake Antivenom

Tuberculin Purified Protein Derivative B.P.

Tuberculin Purified Protein Derivatives, Atypical

 

 

 

Dated this 16th day of November 1988.

 

 

JOHN DEEBLE

ACTING FIRST ASSISTANT SECRETARY

HEALTH BENEFITS DIVISION

DELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH